糖尿病重点 Diabetes in Focus
2003-1
Pharmaceutical Pr
Patel, Anjana
168
Diabetes is a chronic disease affecting millions internationally. Diabetic patients are thus regularly encountered by healthcare workers and the pharmacist is ideally placed to become actively involved in the management of the medicines used by such patients. Diabetes in Focus presents a clear, concise discussion of diabetes as a disease and reviews how the community pharmacist, as a member of a multidisciplinary healthcare team, can become involved in counselling the diabetic patient on their illness, lifestyle, and medicines. Chapters include discussions on the diabetic syndrome, pharmacotherapeutic interventions, medicines management, monitoring, and screening and prevention.
PrefaceAcknowledgementsAbout the authorFocus points1 Introduction2 The diabetic syndrome WHO diagnostic criteria WHO classification criteria3 Prevention and management of diabetic complications Macrovascular complications The diabetic foot Macrovascular complications Antiplatelet therapy4 Lifestyle management Ketoacidosis Non-ketotic hyperosmolar coma Hypoglycaemia Other conditions Exercise Alcohol Smoking Driving Travel Vaccination Complementary/alternative medicines5 Monitoring glycaemic control Blood glucose monitoring Urine glucose and ketone monitoring Glycated haemoglobin Fructosamine Drug interference with blood and urine tests6 Dietary recommendations Glycaemic index of foods Carbohydrates and fibre Fat and triglycerides Protein Salt Dietary supplements7 Pharmacotherapeutic interventions with antidiabetic drugs Type 1 diabetes Type 2 diabetes8 Insulins Indications Mechanism of action Pharmacokinetics Dosage Adverse effects Drug interactions Preparations9 Sulphonylureas Indications Mechanism of action Pharmacokinetics Dosage Adverse effects Drug interactions Preparations10 Mefformin Indications Mechanism of action Contraindications Pharmacokinetics Dosage Adverse effects Drug interactions Preparations11 Acarbose Indications Mechanism of action Pharmacokinetics ……12 Thiazolidinediones(PPAR-γ-agonists)13 Meglitinides14 New therapies and future developments15 Prevention of and screening for diabetes mellitus16 Pharmaceutical assesment of people with diabetesNational Service Framework for Diabetes:Standards2002Glossary Useful resourcesIndex
糖尿病重点 Diabetes in Focus PDF格式下载